Mind Medicine (MindMed) Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Selling, General & Admin	41.74	30.16	59.07	14.4
Research & Development	52.12	36.17	34.79	18.63
Operating Expenses	93.87	66.33	93.85	33.03
Operating Income	-93.87	-66.33	-93.85	-33.03
Interest Expense / Income	0	0	-0.36	0.16
Other Expense / Income	1.87	-9.54	0.7	0.74
Pretax Income	-95.73	-56.8	-94.19	-33.94
Income Tax	0	0	-1.16	0
Net Income	-95.73	-56.8	-93.04	-33.94
Shares Outstanding (Basic)	39	31	27	18
Shares Outstanding (Diluted)	39	31	27	18
Shares Change	26.90%	12.71%	54.25%	-
EPS (Basic)	-2.44	-1.84	-3.40	-1.95
EPS (Diluted)	-2.44	-1.84	-3.40	-1.95
Free Cash Flow	-64.37	-50.14	-45.82	-23.6
Free Cash Flow Per Share	-1.64	-1.63	-1.67	-1.33
EBITDA	-92.57	-53.62	-91.94	-33.77
Depreciation & Amortization	3.16	3.18	2.62	0
EBIT	-95.73	-56.8	-94.55	-33.77

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).